Skip to Main Content

Paper Details

Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.
Cancer Med
4
2019
1, 533,631 SNP Illumina OncoArray, CYP11A1, CYP24A1, CYP27B1, CYP2R1, CYP3A4, CYP3A4/5, EGFR, EGFR region, EOC, GC, HGSOC, SNPs, UGT1A, UGT2A1, UGT2A1/2, UGT2A1/2 region, UGT2B, VDR, Women, epithelial ovarian cancer, rs10017134, rs1017134, rs114972508, vitamin D, vitamin D receptor, vitamin D receptor (VDR) gene, women
Author NameAffiliation
Ani ManichaikulCenter for Public Health Genomics, University of Virginia
Elisa V BanderaRutgers Cancer Institute of New Jersey
Jill S Barnholtz-SloanCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Jill S Barnholtz-SloanCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Patricia G MoormanDuke University Medical Center
Lauren C PeresCenter for Public Health Genomics, University of Virginia
Xin-Qun WangUniversity of Virginia
Andrew BerchuckDuke University Medical Center
Digna R Velez EdwardsCenter for Human Genetics Research, Vanderbilt University Medical Center
Todd L EdwardsCenter for Human Genetics Research, Vanderbilt University Medical Center
Alicia Beeghly-FadielInstitute for Medicine and Public Health, Vanderbilt University Medical Center
Nicolas WentzensenNational Cancer Institute
Celeste Leigh PearceUniversity of Michigan School of ann arbor
Celeste Leigh PearceKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Celeste Leigh PearceUniversity of Michigan School of ann arbor
Celeste Leigh PearceKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Anna H WuKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Anna H WuKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Alice S WhittemoreStanford University School of Medicine
Alice S WhittemoreStanford University School of Medicine
Weiva SiehIcahn School of Medicine at Mount Sinai
Weiva SiehIcahn School of Medicine at Mount Sinai
Joseph H RothsteinIcahn School of Medicine at Mount Sinai
Joseph H RothsteinIcahn School of Medicine at Mount Sinai
Mary Anne RossingFred Hutchinson Cancer Research Center
Mary Anne RossingUniversity of Washington
Jennifer A DohertyHuntsman Cancer Institute, University of Utah
Jennifer A DohertyHuntsman Cancer Institute, University of Utah
Alvaro N A MonteiroMoffitt Cancer Center
Douglas A LevineMemorial Sloan Kettering Cancer Center
Douglas A LevineLaura and Isaac Pearlmutter Cancer Center, New York University Langone Medical Center
Douglas A LevineMemorial Sloan Kettering Cancer Center
Douglas A LevineLaura and Isaac Pearlmutter Cancer Center, New York University Langone Medical Center
Veronica Wendy SetiawanUniversity of Southern California Norris Comprehensive Cancer Center
Christopher A HaimanUniversity of Southern California Norris Comprehensive Cancer Center
Christopher A HaimanUniversity of Southern California Norris Comprehensive Cancer Center
Loic Le MarchandUniversity of Hawaii Cancer Center
Lynne R WilkensUniversity of Hawaii Cancer Center
Lynne R WilkensUniversity of Hawaii Cancer Center
Beth Y KarlanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Usha MenonInstitute of Clinical Trials and Methodology, University College London
Usha MenonInstitute of Clinical Trials and Methodology, University College London
Susan J RamusUniversity of New South Wales
Susan J RamusThe Kinghorn Cancer Centre, Garvan Institute of Medical Research
Susan J RamusUniversity of New South Wales
Susan J RamusThe Kinghorn Cancer Centre, Garvan Institute of Medical Research
Simon A GaytherCenter for Cancer Prevention and Translational Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Simon A GaytherCedars-Sinai Medical Center
Aleksandra Gentry-MaharajInstitute of Clinical Trials and Methodology, University College London
Aleksandra Gentry-MaharajInstitute of Clinical Trials and Methodology, University College London
  • 1 - 50

Datasets